Total Funding
65
61
Total FundingSeed raised
Growth Score 65 in past quarter
-3 pts
Heat Score 61 in past quarter
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
73123
Psy Therapeutics discovers and develops novel medicines to improve the lives of people affected by central nervous system disorders.
Jerrold Rosenbaum: Co-FounderPast Role: Massachusetts General Hospital, Chief of Psychiatry
Maurizio Fava: Co-FounderPast Role: Massachusetts General Hospital, Executive Vice Chair, Department of Psychiatry
About the Company
Psy Therapeutics is discovering and developing novel medicines to improve the lives of people affected by central nervous system (CNS) disorders. The company focuses on anxiety, depression, and dementia to improve neuropsychiatric care.